AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab Dr. Divya Colin13 April 2025 5:30 PM ISTNew Delhi: Pharmaceutical major AstraZeneca Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Dupilumab significantly Reduces COPD Exacerbations in Phase 3 Trials Dr. Shravani Dali17 Feb 2025 9:15 PM ISTResearchers have found in a phase 3 trials that Dupilumab significantly reduced moderate or severe COPD exacerbations compared to placebo in...
Once-Daily Roflumilast Cream Shows Promising for Atopic Dermatitis: JAMA Dr Riya Dave13 Feb 2025 5:45 AM ISTA 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to investigators of phase 3...
Inclisiran Lowers LDL Cholesterol Across Glycaemic and BMI Strata, suggests study Dr Riya Dave17 Aug 2024 9:30 AM ISTResearchers have found that inclisiran significantly lowers LDL cholesterol across various glycaemic and BMI strata, with consistent efficacy and...
Guselkumab Shows Superior Efficacy Over Ustekinumab for treatment of Psoriatic Arthritis: Study Dr Riya Dave13 March 2024 11:45 PM ISTPsoriatic arthritis is a chronic inflammatory condition that affects joints and skin, often causing pain, swelling, and skin lesions. Biologic...
Revise phase III trial protocol: CDSCO Panel tells Bharath Biotech on Inactivated Japanese Encephalitis vaccine Dr. Divya Colin29 Sept 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by vaccine maker Bharath Biotech for a grant of permission to conduct a Phase III clinical trial for...
Fezolinetant reduces frequency and severity of menopausal hot flashes, finds Phase 3 study Dr. Kamal Kant Kohli24 Jun 2022 11:00 AM ISTATLANTA: Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with...
Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride Susmita Roy28 March 2022 7:02 PM ISTNew Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...
Submit in vitro data on safety of Ropivacaine HCL monohydrate delivery: CDSCO panel tells Cipla Dr. Divya Colin20 Feb 2022 12:30 PM ISTNew Delhi: In line with the pharma major Cipla's Phase III clinical trial data for the local anaesthetic drug Ropivacaine HCL monohydrate solution for...
Sun Pharma gets CDSCO panel okay to study antipsychotic drug Pimavanserin capsules Susmita Roy25 Jan 2022 7:54 PM IST
Sun Pharma Dapagliflozin, Glimepiride, Metformin FDC gets CDSCO panel nod for phase 3 trial Medical Dialogues Team24 Nov 2021 6:28 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Pfizer secures CDSCO panel nod to study Hemophilia drug Marstacimab Medical Dialogues Team5 Nov 2021 6:13 PM ISTNew Delhi: In a significant development, drug firm Pfizer has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
